×

Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers

  • US 6,890,918 B2
  • Filed: 04/30/2002
  • Issued: 05/10/2005
  • Est. Priority Date: 04/30/2001
  • Status: Expired due to Fees
First Claim
Patent Images

1. A pharmaceutical composition comprising at least one dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, and at least one bioavailability enhancer selected from ascorbic acid, citric acid, malic acid, fumaric acid, and pharmaceutically acceptable salts of said acids.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×